Latest Breaking News On - Susan leslie clinic - Page 1 : comparemela.com

Lutetium Lu 177 Dotatate Reduced Risk of Death By 72% Compared to Comparator in Patients With Advanced GEP-NETs

Radioligands may be able to deliver radiation to advanced tumor cells anywhere in the body.

Canada
United-states
Toronto
Ontario
Simron-singh
Jeff-legos
University-of-toronto
Novartis
Odette-cancer-centre-in-ontario
Susan-leslie-clinic
Neuroendocrine-tumours
Odette-cancer-centre

'Practice-changing' radioligand therapy may 'redefine' treatment of neuroendocrine tumors

'Practice-changing' radioligand therapy may 'redefine' treatment of neuroendocrine tumors
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

San-francisco
California
United-states
Toronto
Ontario
Canada
Mindy-valcarcel
Simron-singh
Cathy-eng
Byjosh-friedman
Novartis-lutathera
Vanderbilt-ingram-cancer-center

Novartis' innovative drug shows significant positive outcomes in Phase III trial for patients with gastrointestinal cancers - Pharma News

Novartis' innovative drug shows significant positive outcomes in Phase III trial for patients with gastrointestinal cancers - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Toronto
Ontario
Canada
United-states
Sunnybrook
Alberta
American
Jeff-legos
Simron-singh
University-of-toronto
Odette-cancer-centre
American-society-of-clinical-oncology

Novartis Pharma AG: Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

Novartis Pharma AG: Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Switzerland
China
Toronto
Ontario
Canada
Sunnybrook
Alberta
Ivrea
Piemonte
Italy
United-states
Haiyan

Novartis Lutathera® significantly reduced risk of disease progression or death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors

In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs. 8.5 months with high-dose octreotide LAR in patients with newly diagnosed grade 2.

United-states
Haiyan
Yunnan
China
Italy
Sasayama
Hyogo
Japan
Canada
Spain
Zhejiang
Zaragoza